MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-18-0061403
Warkem Biotech Private Limited - chemicals and materials in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹105.06 Cr
▲ 15% YoY
Net profit · FY 2025
₹6.53 Cr
Net margin 6.2%
EBITDA · FY 2025
₹12.3 Cr
EBITDA margin 11.7%
Authorised capital
₹6 Cr
Registered with MCA
Paid-up capital
₹4.89 Cr
Issued & subscribed
Open charges
₹19 Cr
Satisfied ₹15.8 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
151
Provident fund records
About Warkem Biotech Private Limited
Data last updated:
Warkem Biotech Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the organic chemicals and compounds segment of the chemicals and materials sector. It was incorporated on 05 January 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24200MH2005PTC150416. Its GSTIN is 27AAACW5629C1ZF (Maharashtra). The company holds 7 GST registrations, of which 5 are active.
The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹4.89 Cr. It is led by directors including Sheetal Rajas Warke (Whole-Time Director) and Swati Vishnu Warke (Whole-Time Director).
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.C – 40 Road No.21/Y MIDC Wagle Industrial Area, Thane, Maharashtra, India – 400604.
As per the financials filed for FY 2025, the company reported a revenue of ₹105.06 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹6.53 Cr (net margin 6.2%) and EBITDA of ₹12.3 Cr (EBITDA margin 11.7%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 13% over five years.
The company has about 151 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Warkem Biotech. As per MCA filings, the company has open charges of ₹19 Cr and satisfied charges of ₹15.8 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company. The company has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹4.13 Cr; the latest was in February 2017. Its 3 peer companies in the Chemicals industry (Health and Organic Foods, Organic Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 2 smaller; the largest is Inventaa Industries Private Limited with revenue of ₹109.72 Cr. The company has 12 MSME Form 1 returns on record between 2019 and 2024, listing 21 overdue payments to 12 micro and small suppliers.
Warkem Biotech Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0061403). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website warkembiotech.com.
Company details
CIN U24200MH2005PTC150416
Registration Number 150416
Incorporation Date 05 January 2005
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-18-0061403
Key People
Sheetal Rajas Warke Whole-Time Director Swati Vishnu Warke Whole-Time Director Ramesh Tryambak Warke Whole-Time Director Recognitions & Rankings of Warkem Biotech
Contact details
Warkem Biotech Private Limited's registered office is in Thane, Maharashtra. Its website is warkembiotech.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No.C – 40 Road No.21/Y MIDC Wagle Industrial Area, Thane, Maharashtra, India – 400604
- IndustryChemicals and Materials, Organic Chemicals & Compounds
To see the full contact details of Warkem Biotech Private Limited, buy the company report.
Comprehensive company report
Warkem Biotech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Warkem Biotech operates one associated brand: Warkem Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures hydrolyzed proteins for pharmaceuticals, nutraceuticals, and agricultural applications. | warkembiotech.com |
Business activity
The main business activities of Warkem Biotech are manufacturing and support service to organizations. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and other support services to organizations. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| N | Support service to Organizations | N7 | Other support services to organizations |
To see the full business activity and turnover split of Warkem Biotech Private Limited, buy the company report.
Financials of Warkem Biotech Private Limited
FY 2025 filings availableWarkem Biotech Private Limited reported revenue of ₹105.06 Cr (up 15% YoY) for FY 2025.
Revenue · FY 2025
₹105.06 Cr ▲ 15%
Net profit · FY 2025
₹6.53 Cr margin 6.2%
EBITDA · FY 2025
₹12.3 Cr margin 11.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 14%
5 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▲ 35%
3 years · compounded
▲ 20%
5 years · compounded
▲ 9%
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 15% growth in the latest year. EBITDA rose 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12.3 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.53 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.7% | ||||
| Net Profit Margin | 6.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Warkem Biotech Private Limited, buy the company report.
Board of directors of Warkem Biotech Private Limited
Warkem Biotech has 12 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pravin Tryambak Warke | Director | 03 Dec 2014 | 11 Years 10 Months | Current |
| Sheetal Rajas Warke | Whole-Time Director | 16 Jun 2008 | 18 Years 4 Months | Current |
| Gangadhar Motiram Warke | Director | 29 Sep 2014 | 12 Years 0 Months | Current |
| Kishor Bhaskar Chaudhari | Director | 01 Apr 2005 | 21 Years 6 Months | Current |
| Swati Vishnu Warke Also directs: Himedia Laboratories Private Limited | Whole-Time Director | 05 Jan 2005 | 21 Years 9 Months | Current |
| Anil Tryambak Warke | Director | 03 Dec 2014 | 11 Years 10 Months | Current |
Showing 6 of 12 current directors. View all directors
Peer comparison
Warkem Biotech Private Limited is compared with the 3 companies closest to it by revenue in the Chemicals industry (Health and Organic Foods, Organic Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Inventaa Industries Private Limited | ₹109.72 Cr (FY 2025) | -17.0% | Kanchikacherla, Andhra Pradesh, India | |||
| Warkem Biotech Private Limitedthis company | ₹105.06 Cr (FY 2025) | ₹6.53 Cr | 6.2% | 15.0% | 151 | Thane, Maharashtra, India |
| Sanghvi Organics Pvt Ltd | ₹104.31 Cr (FY 2024) | -57.0% | Ankleshwar, Gujarat, India | |||
| Eskay Dyestuffs and Organic Chemicals Pvt Ltd | ₹101.87 Cr (FY 2025) | -8.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Warkem Biotech Private Limited, buy the company report.
Auditor
Warkem Biotech Private Limited is audited by GIRISH S. WATWE & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GIRISH S. WATWE & ASSOCIATES | FY 2023 | 103223W |
Shareholding
The shareholding of Warkem Biotech Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Warkem Biotech Private Limited, buy the company report.
Charges & borrowings
Open charges
₹19 Cr
Satisfied charges
₹15.8 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 May 2005 | 80018767 | State Bank of India | ₹19 Cr | Open | |
| 27 Dec 2005 | 80029183 | State Bank of India | ₹15.8 Cr | Satisfied |
To see the full charge records of Warkem Biotech Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Warkem Biotech Private Limited has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹4.13 Cr; the latest was in February 2017.
Total deals
4
Funding rounds
2
Secondary share transfers
2
Disclosed funding
₹4.13 Cr
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Nov 2013 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Mar 2009 | Funding round | ₹97.5 Lakh | Investors: 4 individuals |
| Nov 2007 | Funding round | ₹3.15 Cr | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Warkem Biotech Private Limited has 2 court cases on record: 2 filed by Warkem Biotech. All cases are disposed.
Total cases
2
Filed by the company
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TELANGANA | Writ petition | Filed by the company against The Commissioner and Director of Agriculture, | Disposed |
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against The Commissioner and Director of Agriculture | Disposed |
To see the full case history of Warkem Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Warkem Biotech Private Limited was last rated by Crisil on 06 Sep 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 06 Sep 2021 |
To see the full credit ratings and regulatory alerts of Warkem Biotech Private Limited, buy the company report.
MSME payment delays
Warkem Biotech Private Limited has 12 MSME Form 1 returns on record between 2019 and 2024, listing 21 overdue payments to 12 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 12)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Swarna Plastics | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Warkem Biotech Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Warkem Biotech Private Limited has a workforce of 151 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
151
Active EPFO establishments
1
Employee growth
9.42%
GST
Warkem Biotech has 7 GST registrations: 5 active and 2 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
7
Active
5
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACW5629C1ZF | Maharashtra | Active | 01 Jul 2017 |
| 36AAACW5629C1ZG | Telangana | Active | 19 Aug 2019 |
| 33AAACW5629C1ZM | Tamil Nadu | Active | 18 Jul 2022 |
| 29AAACW5629C1ZB | Karnataka | Active | 27 Sep 2022 |
To see the full GST registrations and return filing status of Warkem Biotech Private Limited, buy the company report.
Recent activity
Warkem Biotech Private Limited has 18 board changes on record since 2005: 12 appointments and 6 cessations. The latest: Kishor Bhaskar Chaudhari ceased to be Director on 31 Oct 2025.
Ceased
Kishor Bhaskar Chaudhari ceased to be Director.
AGM
Warkem Biotech Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Warkem Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge registered on 27 Dec 2005 via Charge ID 80029183 with State Bank Of India was fully satisfied on 31 Mar 2023.
Charges
A charge with State Bank Of India of Rs. 19.00 Cr registered on 13 May 2005 with Charge ID 80018767 was modified on 01 Aug 2022.
Appointed
Anil Tryambak Warke was appointed as Director.
Appointed
Pravin Tryambak Warke was appointed as Director.
Appointed
Rajas Vishnu Warke was appointed as Director.
Ceased
Ramesh Tryambak Warke ceased to be Director.
Ceased
Saroj Gangadhar Warke ceased to be Managing Director.
Ceased
Swati Vishnu Warke ceased to be Director.
Appointed
Vishal Gangadhar Warke was appointed as Director.
14 earlier events are in the company report.
Frequently asked questions
Warkem Biotech is an active private limited company based in Thane, Maharashtra, India. The company works in organic chemicals and compounds, within the chemicals and materials industry. It was incorporated on 05 January 2005 (21+ years old) and is registered under CIN U24200MH2005PTC150416.
Warkem Biotech has 12 current directors:
- Sheetal Rajas Warke - Whole-Time Director
- Swati Vishnu Warke - Whole-Time Director
- Ramesh Tryambak Warke - Whole-Time Director
- Saroj Gangadhar Warke - Whole-Time Director
- Pravin Tryambak Warke - Director
- Gangadhar Motiram Warke - Director
- Kishor Bhaskar Chaudhari - Director
- Anil Tryambak Warke - Director
- Rahul Gangadhar Warke - Director
- Vishal Gangadhar Warke - Director
- Rajas Vishnu Warke - Director
- Vishnu Motiram Warke - Director
The latest financial statements of Warkem Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Warkem Biotech is 27AAACW5629C1ZF, registered in Maharashtra. The company has 7 GST registrations in all, of which 5 are active and 2 are cancelled or inactive. Other active GSTINs include 36AAACW5629C1ZG (Telangana), 33AAACW5629C1ZM (Tamil Nadu), 29AAACW5629C1ZB (Karnataka).
The CIN (Corporate Identification Number) of Warkem Biotech is U24200MH2005PTC150416. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Warkem Biotech has 2 court cases on record: 2 filed by the company.
Warkem Biotech was incorporated on 05 January 2005, making it 21+ years old. It is registered with the Registrar of Companies, Mumbai.
Warkem Biotech has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹4.13 Cr; the latest was in February 2017.
The peers of Warkem Biotech by revenue are Inventaa Industries Private Limited, Sanghvi Organics Pvt Ltd, Eskay Dyestuffs and Organic Chemicals Pvt Ltd, all in the Chemicals industry (Health and Organic Foods, Organic Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kishor Bhaskar Chaudhari ceased to be Director on 31 Oct 2025. Anil Tryambak Warke was appointed as Director on 03 Dec 2014. Pravin Tryambak Warke was appointed as Director on 03 Dec 2014. Warkem Biotech has 18 board changes on record in total.
Yes, Warkem Biotech is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-18-0061403).
Warkem Biotech has 12 MSME Form 1 returns on record between 2019 and 2024, listing 21 overdue payments to 12 micro and small suppliers. The latest return was filed on 26 Apr 2024.